Delu L. Che
157, Xiwu Road
Xi'an, China
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Correction to Optimization of MrgX2 Antagonists Based on the "Cell Membrane Chromatography-Molecular Docking" Approach.
Journal: Journal of medicinal chemistry
Published: July 09, 2025
Optimization of MrgX2 Antagonists Based on the "Cell Membrane Chromatography-Molecular Docking" Approach.
Journal: Journal of medicinal chemistry
Published: June 17, 2025
MRGPRX2-Mediated Mast Cell Activation Promotes Malignant Progression of Cutaneous Squamous Cell Carcinoma through IL-17A Release.
Journal: The Journal of investigative dermatology
Published: June 01, 2025
Evaluation of the Effects of Chitin and Chitosan on Pseudo-Allergic Reaction by Inhibiting MRGPRX2 Activation.
Journal: Food science & nutrition
Published: March 24, 2025
Isoxanthohumol inhibits MRGPRX2-mediated mast cell activation reducing inflammation in rosacea.
Journal: Chinese medical journal
Published: February 09, 2025
Casticin reduces rosacea-related inflammation by inhibiting mast cell activation via Mas-related G protein-coupled receptor X2.
Journal: Inflammopharmacology
Published: December 09, 2024
Systemic administration of Neochamaejasmin B inhibits mast cell activation to reduce inflammation in a rosacea mouse model by targeting MRGPRX2.
Journal: European journal of pharmacology
Published: November 25, 2024
Epidermal Mechanical Scratching-Induced ROS Exacerbates the Itch-Scratch Cycle through TRPA1 Activation on Mast Cells in Atopic Dermatitis.
Journal: The Journal of investigative dermatology
Published: October 10, 2024
Immobilized protein strategies based on cell membrane chromatography and its application in discovering active and toxic substances in traditional Chinese medicine.
Journal: Pharmacological research
Published: August 30, 2024
Corrigendum to "Decreased TET2/5-hmC reduces the integrity of the epidermal barrier via epigenetic dysregulation of filaggrin in psoriatic lesions" [J. Dermatol. Sci. 113 (2024) 103-112].
Journal: Journal of dermatological science
Published: August 02, 2024
Corrigendum to "Dual effect of tacrolimus on mast cell-mediated allergy and inflammation through MAS-related G protein-coupled receptor-X2" [J. Dermatol. Sci. 112 (2023) 128-137].
Journal: Journal of dermatological science
Published: July 31, 2024
Corrigendum to "p-Phenylenediamine induces immediate contact allergy and non-histaminergic itch via MRGPRX2" [Chem. Biol. Interact. 351 (2022):109751].
Journal: Chemico-biological interactions
Published: May 30, 2024
Last Updated: 09/26/2026